Comparing Midline Catheters and Central Venous Catheters for Patients with Difficult Intravenous Access
Central Venous Catheter vs Midline in Difficulty Access Patient - A Randomized Controlled Clinical Pilot Trial - Pilot-ACCESS-D
This study is testing whether Midline catheters work better than Central Venous Catheters for hospitalized patients who have trouble getting IV access.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Region Jönköping County Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Jönköping, Region Jönköping) |
| Trial ID | NCT06719869 on ClinicalTrials.gov |
What this trial studies
This pilot trial aims to evaluate the effectiveness of Midline catheters versus Central Venous Catheters (CVC) in patients who have difficulty establishing intravenous access. The study will involve 30 hospitalized patients who meet specific criteria for difficult intravenous access, as assessed by trained clinicians. Participants will be randomly assigned to receive either a Midline catheter or a CVC, both guided by ultrasound, in a controlled setting at Ryhov County Hospital in Sweden. The trial follows CONSORT guidelines for pilot studies to ensure rigorous methodology and patient safety.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and over who have a history of difficult intravenous access or have failed multiple attempts at establishing peripheral access.
Not a fit: Patients who are unable to communicate in Scandinavian languages, have cognitive impairments, or are receiving hyperosmolar solutions or chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the comfort and experience of patients requiring intravenous access by reducing the number of needle sticks and complications.
How similar studies have performed: While this approach is being tested in this pilot trial, similar studies have shown promise in improving intravenous access techniques, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* • Age 18 and over
* DIVA criterium fulfilled;
* 2 attempts of venous access by 2 clinicians OR
* No visible nor palpable veins OR
* History of difficult venous access
* 4 - 29 days of catheter dwell time anticipated as assessed by referring clinician.
Exclusion Criteria:
* Unable to speak Scandinavian
* Cognitive Impairment
* Is to receive hyperosmolar solutions (600 milliosmoles/L or above).
* Is to receive chemotherapy
Where this trial is running
Jönköping, Region Jönköping
- Länssjukhuset Ryhov — Jönköping, Region Jönköping, Sweden (Recruiting)
Study contacts
- Principal investigator: Knut Taxbro, MD, PhD — Region Jönköping County
- Study coordinator: Carl Mellander
- Email: carme371@student.liu.se
- Phone: +46 725221218
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.